In a preprint article on bioRxiv, Memorial Sloan Kettering Cancer Center's Maria Jasin, Harvard's George Church, and their colleagues sound a note of scientific caution on a recent Nature study that reported using the gene-editing tool CRISPR/Cas9 to correct a heart disease mutatio
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.